A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Study Director
Takeda
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Border Medical Oncology Research
Albury, New South Wales, Australia
Anish PuliyayilRecruiting - Tweed Hospital
Tweed Heads, New South Wales, Australia
Alejandro ArbelaezRecruiting - Westmead Hospital
Westmead, New South Wales, Australia
John KwanRecruiting - Townsville University Hospital
Douglas, Queensland, Australia
Completed - Royal Adelaide Hospital
Adelaide, South Australia, Australia
Devendra HiwaseRecruiting - Flinders Medical Centre
Bedford Park, South Australia, Australia
David RossRecruiting - Boxhill Hospital
Box Hill, Victoria, Australia
Tse-Chieh TehRecruiting - University Hospital Geelong
Geelong, Victoria, Australia
Hannah RoseRecruiting - Austin Health
Heidelberg, Victoria, Australia
Chun Yew FongRecruiting - Royal Melbourne Hospital
Melbourne, Victoria, Australia
Lynette CheeRecruiting - St Vincent'S Hospital Melbourne
Melbourne, Victoria, Australia
Shuhying TanRecruiting - Ballarat Oncology & Haematology Service
Wendouree, Victoria, Australia
Completed
- Fakultni Nemocnice Brno
Brno, Czechia
Completed - Fakultni Nemocnice Kralovske Vinohrady
Prague, Czechia
Olga CernaRecruiting - Vseobecna Fakultni Nemocnice Praha
Prague, Czechia
Completed
- Chu Angers - Hopital Hotel Dieu
Angers, France
Completed - Chu de Nantes - Hotel Dieu
Nantes, France
Alice GarnierRecruiting - Chu Nice - Hopital de L'Archet 1
Nice, France
Thomas CluzeauRecruiting - Hopital Saint-Louis
Paris, France
Lionel AdesRecruiting - Ch Rene-Dubos
Pontoise, France
Riad BenramdaneRecruiting - Chu de Bordeaux - Hopital Haut-Leveque
Talence, France
Sophie Dimicoli SalazarRecruiting - Centre Hospitalier de la Region Dannecy
Épagny, France
Completed
- Klinikum Bayreuth Gmbh
Bayreuth, Germany
Alexander KianiRecruiting - Charite-Campus Benjamin Franklin
Berlin, Germany
Kathrin RiegerNot, yet, recruiting - Praxis Am Volkspark Berlin
Berlin, Germany
Jan-Piet HabbelNot, yet, recruiting - University Hospital Bonn
Bonn, Germany
Karin MayerNot, yet, recruiting - Marien Hospital Dusseldorf Gmbh
Düsseldorf, Germany
Aristoteles GiagounidisRecruiting - Universitaetsklinikum Duesseldorf Aoer
Düsseldorf, Germany
Completed - Klinikum Esslingen Gmbh
Esslingen am Neckar, Germany
Swen WessendorfRecruiting - University Hospital Halle (saale)
Halle, Germany
Haifa Al-AliNot, yet, recruiting - Universitaetsklinikum Leipzig Aoer
Leipzig, Germany
Completed - Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz
Mainz, Germany
Daniel SascaRecruiting - Universitaetsmedizin Rostock
Rostock, Germany
Completed
- Sheba Medical Center - Sheba Fund for Health Services and Research
Ramat Gan, Israel
Drorit MerkelRecruiting - Sourasky Medical Center - Infrastructure and Health Services Fund of the Tel Aviv Medical Center
Tel Aviv, Israel
Completed
- Middlemore Hospital
Auckland, New Zealand
Completed
- Hospital Universitario Central de Asturias
Barcelona, Spain
Teresa Bernal del CastilloRecruiting - Hospital Universitario Vall D'Hebron
Barcelona, Spain
David Valcarcel FerreirasRecruiting - Ico L'Hospitalet - Hospital Duran I Reynals
Barcelona, Spain
Montserrat Arnan SangermanRecruiting - Hospital Universitario de Salamanca
Salamanca, Spain
Maria Diez CampeloRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Aug 2020
- Primary completion
- 30 Oct 2029
- Completion
- 30 Oct 2031
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 160
- Registry id
- NCT04419649
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.